Enterobacteriaceae Infections: all 59 studies

Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• Aztreonam-Avibactam in Immunocompromised HostsRecruitingNCT07890480
• Genomic and Phenotypic Diversity of Carbapenemase-producing Escherichia Coli Strains Circulating in Southern FranceNot yet recruitingNCT07676513
• Impact of Implementing a Rapid PCR-based Algorithm for Carbapenemase-producing Enterobacterales (CPE) and Infection Control Bundle in a Tertiary HospitalNot yet recruitingNCT07397416Not applicable
• Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant EnterobacteriaRecruitingNCT07345923
• Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant EnterobacteralesNot yet recruitingNCT07160569
• Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill PatientsRecruitingNCT06258551
• Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK ModelNot yet recruitingNCT06210542
• Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant EnterobacteriaceaeNot yet recruitingNCT05981430Not applicable
• Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated AnimalsRecruitingNCT05871476Not applicable
• FMT to Eradicate Intestinal Colonization by Carbapenem-resistant EnterobacteriaceaeRecruitingNCT05791396Phase 1/2
• Fecal Transplantation to Eradicate Colonizing Emergent SuperbugsRecruitingNCT05035342Phase 3
• FMT for the Decolonization of Carbapenem-resistant EnterobacteriaceaeRecruitingNCT04759001Phase 1/2
• Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in ChildrenRecruitingNCT04535661
• PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)RecruitingNCT03671967Phase 4
• Shigella WRSS1 Vaccine Trial in BangladeshCompletedNCT02934178Phase 1Results posted
• Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and ChildrenCompletedNCT01813071Not applicableResults posted
• Study of Probiotic Adjunctive Therapy for Decolonization of Carbapenem-Resistant EnterobacteralesActive, not recruitingNCT07707869Not applicable
• ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNITCompletedNCT07172932
• A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUsCompletedNCT05985057
• Drug Resistance Mechanism of Enterobacteriaceae and Its StrategiesStatus unknownNCT05850871Not applicable
• PMT for MDRO DecolonizationCompletedNCT05632315Phase 2
• Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased PatientsCompletedNCT05611892
• Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant BacteriaStatus unknownNCT05516433
• PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream InfectionsWithdrawnNCT05355350Phase 4
• Cost-effectiveness of Controlling CPEStatus unknownNCT05272410
• Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 PandemicCompletedNCT05055479
• Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum EnterobacteriaceaeStatus unknownNCT04903886
• Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLICStatus unknownNCT04836208
• Fecal Microbiota Transplantation for Carbapenem Resistant EnterobacteriaceaeCompletedNCT04790565Phase 2/3
• Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella PneumoniaeTerminatedNCT04760665Phase 2
• Oral Capsule Faecal Microbiota Transplantation for CPE DecolonizationStatus unknownNCT04746222Phase 2/3
• The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant OrganismsCompletedNCT04583098
• Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care UnitCompletedNCT04528043
• Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.CompletedNCT04276480Not applicable
• Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).Status unknownNCT04190316Not applicable
• Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant EnterobacteriaCompletedNCT04167228
• Fecal Microbiota Transplantation for Carbapenem-resistant EnterobacteriaceaeCompletedNCT04146337Phase 2/3
• Prevention and Decolonization of Multidrug-resistant Bacteria With ProbioticsStatus unknownNCT03967301Not applicable
• Community-associated Highly-Resistant EnterobacteralesCompletedNCT03924934
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing EnterobacteriaceaeSuspendedNCT03891433Phase 4
• Pilot Study Using Oral Capsule FMT to Decolonize GI CREWithdrawnNCT03527056Early Phase 1
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK, the Measure of How the Human Body Processes a Substance) of ETX0282 When Administered Orally to Healthy ParticipantsCompletedNCT03491748Phase 1
• Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care FacilitiesCompletedNCT03477084
• The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian ToddlersStatus unknownNCT03411590Not applicable
• Prevalence of ESBL and CPE in French Nursing HomesCompletedNCT03401242
• Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant BacteriaCompletedNCT03338738Not applicable
• Qnr Genes in EnterobacteriaceaeCompletedNCT02834910
• Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by EnterobacteriaceaeCompletedNCT02795949Phase 3
• Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From BloodCompletedNCT02482051
• 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected InfectionStatus unknownNCT02450942Early Phase 1
• Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by EnterobacteriaceaeCompletedNCT02400268Phase 3
• Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate BiopsyCompletedNCT02140502
• The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in TaiwanCompletedNCT01725841
• Carriage Of Multiresistant Bacteria After TravelCompletedNCT01676974
• The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss ChildrenStatus unknownNCT00894036
• Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization StudyCompletedNCT00826670Phase 4
• Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing OrganismsCompletedNCT00573521
• Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia ColiCompletedNCT00573235
• Infections Caused by ESbL-Producing Enterobacteriaceae in ItalyStatus unknownNCT00404625

← Enterobacteriaceae Infections overview